Additionally, while it would have been interesting to explore the influence of HLA-KIR ligand pairs (i.e. KIR2DL1/HLA-C*06:02 and KIR3DL1/HLA-B*53:01) on malaria outcomes, the prevalence of both of these inhibitory KIR in our cohort was >98% (19). This evidence concerns the gene HLA-B and malaria.